Review10.1007/978-1-4615-1823-5_39

Development of Active Specific Immunotherapeutic Agents Based on Cancer-Associated Mucins

John Samuel,B. Michael Longenecker-1995-01-01-Pharmaceutical biotechnology

15

Chat with Paper

AI Agents for this Paper

No abstract available for this paper.

Keywords

Immune systemCancerBiologyImmunologyCancer immunotherapyFirst lineCancer cellMucin

Chat

Click to start Chat